Press Release

Printer Friendly Version View printer-friendly version
<< Back
POZEN To Present at the 2006 RBC Capital Markets Healthcare Conference

CHAPEL HILL, N.C., Dec 07, 2006 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ:POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president & CEO, will participate in the "House of Pain Relief" panel at the 2006 RBC Capital Markets Healthcare Conference on Thursday, December 14, 2006 at 10:00 a.m. (EST) at the New York Westin-Times Square in New York City. Dr. Plachetka's presentation will be webcast and archived on POZEN's home page at www.pozen.com.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for the proposed product candidate Trexima(TM) combining sumatriptan, formulated with RT technology, and naproxen sodium in a single tablet for the acute treatment of migraine, which is currently under review by the United States Food and Drug Administration, and with AstraZeneca for proprietary fixed dose combinations of the proton pump inhibitor esomeprazole magnesium with naproxen in a single tablet for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

SOURCE: POZEN Inc.

POZEN Inc. Bill Hodges, Chief Financial Officer, 919-913-1030 Fran Barsky, Director, Investor Relations, 919-913-1044


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.